Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Current Assets: 2021-2022

Historic Current Assets for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $52.0 million.

  • Cardiol Therapeutics' Current Assets rose 111.37% to $52.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $52.0 million, marking a year-over-year increase of 111.37%. This contributed to the annual value of $69.5 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Cardiol Therapeutics reported Current Assets of $52.0 million as of Q3 2022, which was down 10.03% from $57.7 million recorded in Q2 2022.
  • Cardiol Therapeutics' Current Assets' 5-year high stood at $69.1 million during Q4 2021, with a 5-year trough of $24.6 million in Q3 2021.
  • Moreover, its 2-year median value for Current Assets was $54.8 million (2022), whereas its average is $49.1 million.
  • Data for Cardiol Therapeutics' Current Assets shows a peak YoY spiked of 111.37% (in 2022) over the last 5 years.
  • Over the past 2 years, Cardiol Therapeutics' Current Assets (Quarterly) stood at $69.1 million in 2021, then skyrocketed by 111.37% to $52.0 million in 2022.
  • Its last three reported values are $52.0 million in Q3 2022, $57.7 million for Q2 2022, and $62.2 million during Q1 2022.